Page last updated: 2024-10-26

2,3-dimethoxy-1,4-naphthoquinone and Leukemia, Erythroblastic, Acute

2,3-dimethoxy-1,4-naphthoquinone has been researched along with Leukemia, Erythroblastic, Acute in 1 studies

2,3-dimethoxynaphthalene-1,4-dione : A naphthoquinone that is 1,4-naphthoquinone bearing two methoxy substituents at positions 2 and 3. Redox-cycling agent that induces intracellular superoxide anion formation and, depending on the concentration, induces cell proliferation, apoptosis or necrosis. Used to study the role of ROS in cell toxicity, apoptosis, and necrosis.

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgan, WA1

Other Studies

1 other study available for 2,3-dimethoxy-1,4-naphthoquinone and Leukemia, Erythroblastic, Acute

ArticleYear
Naphthoquinone-induced DNA damage in the absence of oxidative stress.
    Biochemical Society transactions, 1995, Volume: 23, Issue:2

    Topics: Cell Line; DNA Damage; DNA, Neoplasm; Humans; Leukemia, Erythroblastic, Acute; NAD; Naphthoquinones;

1995